⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL868159 | 0.73 | — | — | |
| SCHEMBL42495 | 0.73 | — | — | |
| SCHEMBL868501 | 0.73 | — | — | |
| SCHEMBL1973936 | 0.72 | — | — | |
| SCHEMBL27401 | 0.70 | — | — | |
| SCHEMBL97943 | 0.70 | — | — | |
| SCHEMBL5279629 | 0.68 | — | — | |
| SCHEMBL1040886 | 0.67 | — | — | |
| Water SCHEMBL11060017 | 0.67 | ALDH1A1 (0.33) | — | |
| SCHEMBL13020450 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3049378-A1 | PREPARATION OF RADIOIODINATED 3-FLUOROPROPYL-NOR-BETA-CIT | Mallinckrodt LLC (US) | 2016-08-03 | — | — | EP | claimed |
| WO-2015048250-A1 | PREPARATION OF RADIOIODINATED 3-FLUOROPROPYL-NOR-BETA-CIT | MALLINCKRODT LLC (US) | 2015-04-02 | — | — | WO | claimed |
| EP-1349859-A2 | TRIAZOLOPYRIMIDINES | Bayer CropScience AG (DE) | 2003-10-08 | — | — | EP | claimed |
| WO-2002050077-A2 | TRIAZOLOPYRIMIDINES | BAYER CROPSCIENCE AG (DE) | 2002-06-27 | — | — | WO | claimed |
| US-20260091029-A1 | VMAT2 INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | LUYE INNOMIND PHARMA SHIJIAZHUANG CO LTD (CN) | 2026-04-02 | — | — | US | disclosed |
| US-12565495-B2 | VMAT2 inhibitor and preparation method therefor and application thereof | LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. (CN) | 2026-03-03 | — | — | US | disclosed |
| EP-3541809-B1 | NOVEL SUBSTITUTED N-(3-FLUOROPROPYL)-PYRROLIDINE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF | SANOFI SA (FR) | 2025-06-25 | — | — | EP | disclosed |
| CN-115260186-B | VMAT2 inhibitor and preparation method and application thereof | 山东绿叶制药有限公司 | 2024-05-28 | — | — | CN | disclosed |
| EP-4351560-A1 | ANTICANCER COMPOUNDS | The Regents of the University of California (US) | 2024-04-17 | — | — | EP | disclosed |
| EP-4326718-A1 | NOVEL ERGOLINES AND METHODS OF TREATING MOOD DISORDERS | Gilgamesh Pharmaceuticals, Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2024039861-A1 | 2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOLE DERIVATIVES AS ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF CANCER | OLEMA PHARMACEUTICALS, INC. (US) | 2024-02-22 | — | — | WO | disclosed |
| EP-4323329-A1 | NITROPHENYL-ACRYLAMIDES AND USES THEREOF | Brown University (US) | 2024-02-21 | — | — | EP | disclosed |
| WO-1996039198-A1 | IODINATED NEUROPROBES FOR MAPPING MONOAMINE REUPTAKE SITES | RESEARCH BIOCHEMICALS, LIMITED PARTNERSHIP, doing business as RESEARCH BIOCHEMICALS INTERNATIONAL, A MASSACHUSETTS LIMITED PARTNERSHIP, WHOSE SOLE GENERAL PARTNER IS RBI MANAGEMENT, INC. (US) | 1996-12-12 | — | — | WO | disclosed |
| EP-0718264-A1 | A liquid crystalline compound containing fluorine atom substituted alkyl group(s) and a liquid crystal composition | Chisso Corporation (JP) | 1996-06-26 | — | — | EP | disclosed |
| EP-0703791-A4 | AN IODINATED NEUROPROBE FOR MAPPING MONOAMINE REUPTAKE SITES | RES BIOMED LP (US) | 1996-05-22 | — | — | EP | disclosed |
| EP-0703791-A1 | AN IODINATED NEUROPROBE FOR MAPPING MONOAMINE REUPTAKE SITES | RESEARCH BIOMEDICALS LIMITED PARTNERSHIP (US) | 1996-04-03 | — | — | EP | disclosed |
| EP-0656892-A1 | HERBICIDAL 2- (4-HETEROCYCLIC-PHENOXYMETHYL)PHENOXY]-ALKANOATES | FMC CORPORATION (US) | 1995-06-14 | — | — | EP | disclosed |
| EP-0649413-A1 | URACIL DERIVATIVES AS ENZYME INHIBITORS | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-04-26 | — | — | EP | disclosed |
| WO-1994001414-A1 | URACIL DERIVATIVES AS ENZYME INHIBITORS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-01-20 | — | — | WO | disclosed |
| US-4801750-A | Process for the produciton of 2-chloroacetoacetic acid amides | LONZA LTD. (CH) | 1989-01-31 | — | — | US | disclosed |